Pharma Industry News Weekly Recap: July 8, 2021
Jardiance Becomes First SGLT2 Inhibitor to Show Benefit in HFpEF July 7, 2021 Cardiovascular / Diabetes / Pharmaceuticals Eli [...]
Jardiance Becomes First SGLT2 Inhibitor to Show Benefit in HFpEF July 7, 2021 Cardiovascular / Diabetes / Pharmaceuticals Eli [...]
Lilly, Novo Nordisk Present Promising Data in Type 2 Diabetes June 28, 2021 Diabetes / Pharmaceuticals Eli Lilly's investigational diabetes [...]
3D Printing Provides a Potential Cure for Diabetes June 22, 2021 Diabetes / Biotech / 4IR - 3D Printing Readily3D, [...]
While Covid-19 was ravaging our country over the past year, America was also fighting another epidemic: the ongoing battle against [...]
60 days until the J.P. Morgan 38th annual Healthcare Conference (#JPM2020). Removing the upcoming holidays and weekends, we’re talking 36 [...]
Investors Hunt for Biotech Winners as Wider Stock Market Churns October 19, 2018 Biotech / FinanceSince hitting a 52-week [...]
Slowly, but ever so surely, the diabetes treatment landscape is evolving along two continuums. The first is the world of [...]
Diabetes, once considered a disease of the pancreas, is now understood to be a complex, multi-hormonal disease leading to devastating [...]
Pharma’s ‘Come-to-Jesus Moment’: The Industry Braces for a Pelosi Speakership & Democrats’ Drug Pricing Agenda October 30, 2018 PharmaNancy [...]
The FDA isn’t tech’s biggest hurdle to the healthcare system October 24, 2018 Technology The impact of health tech [...]